DOI: 10.4244/EIJV13I17A341

Reply to the letter to the editor by Yaeger regarding the article “In vivo validation of mathematically derived fractional flow reserve for assessing haemodynamics of coronary tandem lesions”

We appreciate the interest in our article1. The author raised the issues of the driving force for myocardial flow, the flow ratio estimation, and the procedural order. Also, the author suggested that the application of the prediction model in Yaeger2 would improve the outcomes of FFR prediction.

Spaan et al3 showed that, even without collateral flows, (Pd–Pv)/(Pa–Pv) overestimates the coronary flow ratio (QS/QN) and the microvascular resistance (Rmin) increases as the distal pressure (Pd) falls. To build an equation to describe the P–Q relationship better, we introduced “R” corresponding to the inverse of the slope for Q vs. Pd–Pw, instead of using a constant microvascular resistance (Figure4 in Spaan et al3). The flow ratios to branches, in the same regard, were estimated using anatomical metrics. Because “R” in our mathematical derivation is dimensionally equivalent to the resistance in electronic circuit modelling, we called it “resistance”.

For determining the procedural order, previous studies have recommended that treatment of the stenosis with greater pressure or FFR gradient during pressure wire pullback should be prioritised4, as addressed in the introduction of our article1. Please remember that the objective of our work was to propose a better method for predicting more severe lesions.

The prediction model of Yaeger2 was examined and the outcomes are listed in Table 1. The mean error was 0.057±0.059 and the mean absolute error was 0.063±0.052. In the Appendix, please find the translation of Yaeger’s prediction model2 to the notations in our derivation.

Appendix. Translation of Yaeger’s prediction model to the notations in the derivation by Kweon et al

For simplicity, abbreviations are used as follows.

FFRapp(LM)=a

FFRtrue(LM)=b

FFRapp(LAD) =FFRtrue(LAD)=c Eq (*1)

FFRreal(LM)=d

FFRreal(LAD)=e

From the pullback measurement, FFRapp(LM) and FFRapp(LAD) are obtained. For the comparison with our mathematical model, we rephrased the equations in Yaeger2 as functions of “a” and “c” as follows.

Equation (19) in Yaeger2 is:

Using the abbreviations above, it becomes:

Eq (*2)

By multiplying both numerator and denominator by 2b, we can get:

.

By multiplying both sides by the denominator, it becomes:

a(1+b+c–bc)=2b and a(1+c)=b(ac–a+2).

Subsequently, b can be expressed as:

. Eq (*3)

Equation (23) in Yaeger2 is:

.

Using the abbreviations above, it becomes:

.

Using the expression in Eq (*3), we can get:

.

Using the notations in Yaeger2, the prediction equation for LAD treatment becomes:

.

Equation (34) for the LM treatment in Yaeger2 is:

.

Using the abbreviations above, it becomes:

.

Using the expression in Eq (*2), we can get:

e=ac.

Using the notations in Yaeger2, the prediction equation for LM treatment becomes:

FFRreal (LAD)=FFRapp (LM)×FFRtrue (LAD).

Using the notations in our derivation, the equations above are translated as follows:

for proximal treatment,

for distal treatment.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Supplementary data

Both of the letters to the Editor disputing the paper, “Invivo validation of mathematically derived fractional flow reserve for assessing haemodynamics of coronary tandem lesions”1, together with all further correspondence can be found online in the Supplementary data.

To read the full content of this article, please download the PDF.

Volume 13 Number 17
Apr 20, 2018
Volume 13 Number 17
View full issue


Key metrics

Suggested by Cory

10.4244/EIJV12I11A219 Dec 9, 2016
FFR in daily clinical practice: from “Prêt-à-Porter” to “Haute Couture”
Finet G and Rioufol G
free

Clinical research

10.4244/EIJ-D-18-00668 Oct 18, 2019
Personalised fractional flow reserve: a novel concept to optimise myocardial revascularisation
Gosling R et al
free

10.4244/EIJV13I2A20 Jun 2, 2017
Coronary physiological parameters at a crossroads
Davies J et al
free
Trending articles
202.75

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
87.2

State-of-the-Art

10.4244/EIJ-D-25-00266 Jan 19, 2026
Lesion stratification with intracoronary imaging
McGarvey M et al
free
47.45

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
35.3

Original Research

10.4244/EIJ-D-25-01006 Mar 16, 2026
Clinical outcomes and haemodynamic response after blinded stress assessment of moderate aortic stenosis
Eerdekens R et al
32.2

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
27.1

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
27.1

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
22.2

Viewpoint

10.4244/EIJ-D-25-01066 May 4, 2026
Intracoronary imaging guidance for de novo coronary lesion treatment with drug-coated balloons
Amabile N et al
free
20.75

Flashlight

10.4244/EIJ-D-25-01014 Apr 6, 2026
Stent retriever-assisted coronary thrombectomy with continuous aspiration
Liabot Q et al
open access
19.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved